BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

710 related articles for article (PubMed ID: 28230061)

  • 1. Neurofibromatosis type 1.
    Gutmann DH; Ferner RE; Listernick RH; Korf BR; Wolters PL; Johnson KJ
    Nat Rev Dis Primers; 2017 Feb; 3():17004. PubMed ID: 28230061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic basis of neurofibromatosis type 1 and related conditions, including mosaicism.
    Legius E; Brems H
    Childs Nerv Syst; 2020 Oct; 36(10):2285-2295. PubMed ID: 32601904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibromatosis type 1.
    Anderson JL; Gutmann DH
    Handb Clin Neurol; 2015; 132():75-86. PubMed ID: 26564071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical diagnosis of neurofibromatosis type 1].
    Wolkenstein P; Zeller J
    Presse Med; 1999 Dec; 28(39):2174-80. PubMed ID: 10629698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofibromatosis 1: from lab bench to clinic.
    Ward BA; Gutmann DH
    Pediatr Neurol; 2005 Apr; 32(4):221-8. PubMed ID: 15797177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical study of type 1 neurofibromatosis in north west England.
    McGaughran JM; Harris DI; Donnai D; Teare D; MacLeod R; Westerbeek R; Kingston H; Super M; Harris R; Evans DG
    J Med Genet; 1999 Mar; 36(3):197-203. PubMed ID: 10204844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and genetic aspects of neurofibromatosis 1.
    Jett K; Friedman JM
    Genet Med; 2010 Jan; 12(1):1-11. PubMed ID: 20027112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ophthalmological manifestations in segmental neurofibromatosis type 1.
    Ruggieri M; Pavone P; Polizzi A; Di Pietro M; Scuderi A; Gabriele A; Spalice A; Iannetti P
    Br J Ophthalmol; 2004 Nov; 88(11):1429-33. PubMed ID: 15489488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofibromatosis from Head to Toe: What the Radiologist Needs to Know.
    Wang MX; Dillman JR; Guccione J; Habiba A; Maher M; Kamel S; Panse PM; Jensen CT; Elsayes KM
    Radiographics; 2022; 42(4):1123-1144. PubMed ID: 35749292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a multidisciplinary clinic of neurofibromatosis type 1 and other neurocutaneous disorders in Greece. A 3-year experience.
    Kokkinou E; Roka K; Alexopoulos A; Tsina E; Nikas I; Krallis P; Thanopoulou I; Nasi L; Makrygianni E; Tsoutsou E; Kosma K; Tsipi M; Tzetis M; Frysira H; Kattamis A; Pons R
    Postgrad Med; 2019 Sep; 131(7):445-452. PubMed ID: 31443616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neurofibromatosis type 1 or Von Recklinghausen's disease].
    Pinson S; Wolkenstein P
    Rev Med Interne; 2005 Mar; 26(3):196-215. PubMed ID: 15777582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Segmental neurofibromatosis in childhood.
    Listernick R; Mancini AJ; Charrow J
    Am J Med Genet A; 2003 Aug; 121A(2):132-5. PubMed ID: 12910491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Café-au-lait Macules and Neurofibromatosis Type 1: A Review of the Literature.
    Bernier A; Larbrisseau A; Perreault S
    Pediatr Neurol; 2016 Jul; 60():24-29.e1. PubMed ID: 27212418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neurofibromatosis--an inborn genetic disorder with susceptibility to neoplasia].
    Karwacki MW; Woźniak W
    Med Wieku Rozwoj; 2006; 10(3 Pt 2):923-48. PubMed ID: 17401183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Jaffe-Campanacci syndrome or neurofibromatosis type 1: a case report of phenotypic overlap with detection of NF1 gene mutation in non-ossifying fibroma.
    Vannelli S; Buganza R; Runfola F; Mussinatto I; Andreacchio A; de Sanctis L
    Ital J Pediatr; 2020 May; 46(1):58. PubMed ID: 32393377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early-onset stroke in two siblings with Neurofibromatosis type 1.
    Rukavina K; Töpper R; Kunze A; Hess A; Glatzel M; Valdueza JM; Farschtschi S; Hagel C
    Eur J Med Genet; 2019 Oct; 62(10):103710. PubMed ID: 31279841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Developmental manifestation in children with neurofibromatosis type 1].
    Cohen R; Shuper A
    Harefuah; 2010 Jan; 149(1):49-52, 61. PubMed ID: 20422842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neurofibromatosis type 1 - description of clinical features and molecular mechanism of the disease].
    Bikowska-Opalach B; Jackowska T
    Med Wieku Rozwoj; 2013; 17(4):334-40. PubMed ID: 24519776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neurofibromatosis type 1 and associated clinical abnormalities in 27 children].
    Syrbe S; Eberle K; Strenge S; Bernhard MK; Herbertz S; Bierbach U; Hirsch W; Froster UG; Kiess W; Merkenschlager A
    Klin Padiatr; 2007; 219(6):326-32. PubMed ID: 18183640
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 36.